The discussion extended beyond the United States, touching on pricing pressures in Europe. Different countries are implementing their approaches to address pricing issues. In France, some products are deemed non-reimbursable, leading to no price negotiations. Germany's AMNOG negotiation process has led to drug withdrawals, while the UK uses net pricing strategies to exert pressure. The global macroeconomic environment, particularly post-COVID, is adding budgetary pressures across the board.